Quantum dot-based quantification revealed differences in subcellular localization of EGFR and E-cadherin between EGFR-TKI sensitive and insensitive cancer cells.
about
Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer.Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine.Small-molecule Bax agonists for cancer therapy.Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma.Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.Nanotechnology in thoracic surgery.Targeted extracellular nanoparticles enable intracellular detection of activated epidermal growth factor receptor in living brain cancer cells.Bcl2 inhibition of mitochondrial DNA repair.Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer.Biomarker quantification by multiplexed quantum dot technology for predicting lymph node metastasis and prognosis in head and neck cancer.Gold nanoparticles and quantum dots for bioimaging.Quantum dots: bright and versatile in vitro and in vivo fluorescence imaging biosensors.Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR.RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy.DIAPH3 governs the cellular transition to the amoeboid tumour phenotype.Apical and Basal Matrix Remodeling Control Epithelial Morphogenesis.
P2860
Q31138064-248CCA1E-A0F7-4D57-885F-FD6E6B200952Q34033804-5B7E854A-A97A-4D6E-AAF2-C9C9152091F2Q34231198-088790D8-51BE-4E21-896B-E2472B477330Q34644985-46100FC2-15D8-4D20-95EE-36FCAE1E432AQ34657670-4C0E36F6-6C52-40DC-A407-65F927A15B0FQ34993848-5A552C21-C65C-4266-8122-E16EC89E16B8Q35577104-D85AD372-0C60-4AE7-9A83-E95AB7A36BB7Q35744299-F11AFF11-3EBF-4C82-89EF-3E93F89D6B20Q37227498-220FBE9C-094F-42F7-B4F9-C0A1517BDA73Q37536993-319E9CA3-CDEC-4D6F-BF89-0F898A03C8BDQ37787145-F9593732-46F8-411C-841A-99922CABA03DQ38380533-CADC35E5-ADFF-4608-B314-AC066C77A940Q38696292-BD9BC1EF-C57B-425F-B81D-8A1ECC65EC21Q39146064-CF7716EA-7816-412B-96D7-F3279E84F681Q39347119-28EF250A-AFB7-4379-9B08-C403C1001850Q55510149-22A736D1-BB25-47F8-92DC-6DCB1673FDF3
P2860
Quantum dot-based quantification revealed differences in subcellular localization of EGFR and E-cadherin between EGFR-TKI sensitive and insensitive cancer cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Quantum dot-based quantificati ...... and insensitive cancer cells.
@en
Quantum dot-based quantificati ...... and insensitive cancer cells.
@nl
type
label
Quantum dot-based quantificati ...... and insensitive cancer cells.
@en
Quantum dot-based quantificati ...... and insensitive cancer cells.
@nl
prefLabel
Quantum dot-based quantificati ...... and insensitive cancer cells.
@en
Quantum dot-based quantificati ...... and insensitive cancer cells.
@nl
P2093
P356
P1433
P1476
Quantum dot-based quantificati ...... and insensitive cancer cells.
@en
P2093
Dong M Shin
Dong-Hai Huang
Fadlo R Khuri
Hongzheng Zhang
Xiang-Hong Peng
Zhuo Georgia Chen
P304
P356
10.1088/0957-4484/20/22/225102
P50
P577
2009-05-12T00:00:00Z